These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 35611953)

  • 21. Hydroxysafflor yellow A of Carthamus tinctorius attenuates lung injury of aged rats exposed to gasoline engine exhaust by down-regulating platelet activation.
    Wang C; Wang C; Ma C; Huang Q; Sun H; Zhang X; Bai X
    Phytomedicine; 2014 Feb; 21(3):199-206. PubMed ID: 24192212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hydroxysafflor yellow A inhibits TGF-β1-induced activation of human fetal lung fibroblasts in vitro.
    Pan R; Zhang Y; Zang B; Tan L; Jin M
    J Pharm Pharmacol; 2016 Oct; 68(10):1320-30. PubMed ID: 27457091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antioxidant effects of hydroxysafflor yellow A and acetyl-11-keto-β-boswellic acid in combination on isoproterenol-induced myocardial injury in rats.
    Chen M; Wang M; Yang Q; Wang M; Wang Z; Zhu Y; Zhang Y; Wang C; Jia Y; Li Y; Wen A
    Int J Mol Med; 2016 Jun; 37(6):1501-10. PubMed ID: 27121241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydroxysafflor yellow A, a natural compound from Carthamus tinctorius L with good effect of alleviating atherosclerosis.
    Xue X; Deng Y; Wang J; Zhou M; Liao L; Wang C; Peng C; Li Y
    Phytomedicine; 2021 Oct; 91():153694. PubMed ID: 34403879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydroxysafflor yellow A suppresses angiogenesis of hepatocellular carcinoma through inhibition of p38 MAPK phosphorylation.
    Zhang J; Li J; Song H; Xiong Y; Liu D; Bai X
    Biomed Pharmacother; 2019 Jan; 109():806-814. PubMed ID: 30551534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative Analysis of the Effects of Hydroxysafflor Yellow A and Anhydrosafflor Yellow B in Safflower Series of Herb Pairs Using Prep-HPLC and a Selective Knock-Out Approach.
    Qu C; Wang LY; Jin WT; Tang YP; Jin Y; Shi XQ; Shang LL; Shang EX; Duan JA
    Molecules; 2016 Nov; 21(11):. PubMed ID: 27827969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hydroxysafflor yellow A cardioprotection in ischemia-reperfusion (I/R) injury mainly via Akt/hexokinase II independent of ERK/GSK-3β pathway.
    Min J; Wei C
    Biomed Pharmacother; 2017 Mar; 87():419-426. PubMed ID: 28068632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hydroxysafflor Yellow A Protects Neurons From Excitotoxic Death through Inhibition of NMDARs.
    Wang X; Ma Z; Fu Z; Gao S; Yang L; Jin Y; Sun H; Wang C; Fan W; Chen L; Zheng QY; Bi G; Ma CL
    ASN Neuro; 2016; 8(2):. PubMed ID: 27067428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydroxysafflor Yellow A and Anhydrosafflor Yellow B Protect Against Cerebral Ischemia/Reperfusion Injury by Attenuating Oxidative Stress and Apoptosis
    Fangma Y; Zhou H; Shao C; Yu L; Yang J; Wan H; He Y
    Front Pharmacol; 2021; 12():739864. PubMed ID: 34658877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hydroxysafflor yellow A attenuate lipopolysaccharide-induced endothelium inflammatory injury.
    Jin M; Sun CY; Zang BX
    Chin J Integr Med; 2016 Jan; 22(1):36-41. PubMed ID: 26015073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hydroxysafflor Yellow A Confers Neuroprotection from Focal Cerebral Ischemia by Modulating the Crosstalk Between JAK2/STAT3 and SOCS3 Signaling Pathways.
    Yu L; Liu Z; He W; Chen H; Lai Z; Duan Y; Cao X; Tao J; Xu C; Zhang Q; Zhao Z; Zhang J
    Cell Mol Neurobiol; 2020 Nov; 40(8):1271-1281. PubMed ID: 32060857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hydroxysafflor yellow A attenuates lymphostatic encephalopathy-induced brain injury in rats.
    Pan Y; Zheng DY; Liu SM; Meng Y; Xu HY; Zhang Q; Gong J; Xia ZL; Chen LB; Li HY
    Phytother Res; 2012 Oct; 26(10):1500-6. PubMed ID: 22318911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hydroxysafflor Yellow A Promotes Angiogenesis via the Angiopoietin 1/ Tie-2 Signaling Pathway.
    Chen T; Chen N; Pang N; Xiao L; Li Y; Li R; Luo M; Deng X; Ren M; Wu J; Wang L
    J Vasc Res; 2016; 53(5-6):245-254. PubMed ID: 27894114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Inhibitory action of hydroxysafflor yellow A on inflammatory signal transduction pathway related factors in rats with cerebral cortex ischemia].
    Chen TT; Du YJ; Liu XL; Zhu HB
    Yao Xue Xue Bao; 2008 Jun; 43(6):570-5. PubMed ID: 18822957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Research progress on mechanism of Carthamus tinctorius in ischemic stroke therapy].
    Chen JR; Xie XF; Cao XY; Li GM; Yin YP; Peng C
    Zhongguo Zhong Yao Za Zhi; 2022 Sep; 47(17):4574-4582. PubMed ID: 36164862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hydroxysafflor yellow A up-regulates HIF-1alpha via inhibition of VHL and p53 in Eahy 926 cell line exposed to hypoxia].
    Lian ZQ; Zhao DL; Zhu HB
    Yao Xue Xue Bao; 2008 May; 43(5):484-9. PubMed ID: 18717335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hydroxysafflor yellow A promotes osteogenesis and bone development via epigenetically regulating β-catenin and prevents ovariectomy-induced bone loss.
    Wang P; Wang M; Zhuo T; Li Y; Lin W; Ding L; Zhang M; Zhou C; Zhang J; Li G; Wang H; Xu L
    Int J Biochem Cell Biol; 2021 Aug; 137():106033. PubMed ID: 34216755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective effect of hydroxysafflor yellow A on bleomycin- induced pulmonary inflammation and fibrosis in rats.
    Jin M; Wang L; Wu Y; Zang BX; Tan L
    Chin J Integr Med; 2018 Jan; 24(1):32-39. PubMed ID: 29294256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hydroxysafflor Yellow A Attenuates Lipopolysaccharide-Induced Neurotoxicity and Neuroinflammation in Primary Mesencephalic Cultures.
    Wang T; Ding YX; He J; Ma CJ; Zhao Y; Wang ZH; Han B
    Molecules; 2018 May; 23(5):. PubMed ID: 29783643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatoprotective effects of hydroxysafflor yellow A in D-galactose-treated aging mice.
    Min F; Sun H; Wang B; Ahmad N; Guo H; Gao H; Gao Y; Liu X; Li H
    Eur J Pharmacol; 2020 Aug; 881():173214. PubMed ID: 32454116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.